 evaluation patients human immunodeficiency virus-related disorders brain mass lesions patients risk immunodeficiency syndrome mass lesion dilemma toxoplasmosis brain biopsy present data indications brain biopsy vs empiric treatment charts patients acquired immunodeficiency syndrome related disorders cerebral mass lesions Thirty-two patients diagnostic criteria toxoplasmosis Bayesian analysis prior probability toxoplasmosis presence contrast enhancement computed tomographic scans toxoplasmosis titers Features probabilities toxoplasmosis absence contrast enhancement computed tomographic scans toxoplasmosis titers equal percent patients complications brain biopsy Treatment pyrimethamine sulfadiazine complications serious complications treated patients data favor empiric therapy patients typical features toxoplasmosis brain biopsy defined subsets patients atypical features